Research And Trials
How is CRISPR genome editing helping harness the power of immunotherapy?
Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.
Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.
News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?
Immunotherapies are showing promise but not for every tumour, calls for boys to be vaccinated against HPV, and... what's killer about sofas? Find out in the news digest....
At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.
Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.
How do you study cell division, without cells?
News digest – cutting sugar, a new NHS target, lab-grown mini tumours, and… vitamin C as a treatment?
New guidelines to help cut sugar levels, old and new cancer waiting targets, tools to improve diagnosis, and... why is vitamin C in the headlines? We explain all in the...
New research predicts that 2 in 3 cancers are ‘due to bad luck’, we look at why the story is a bit more complicated than that.
We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.